Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
According to Abbott Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 38.1805. At the end of 2022 the company had a P/E ratio of 25.6.
Year | P/E ratio | Change |
---|---|---|
2022 | 25.6 | -27.43% |
2021 | 35.2 | -18.34% |
2020 | 43.1 | 3.71% |
2019 | 41.6 | -22.4% |
2018 | 53.6 | -74.09% |
2017 | 207 | 412.58% |
2016 | 40.4 | 167.34% |
2015 | 15.1 | -49.14% |
2014 | 29.7 | 28.56% |
2013 | 23.1 | 178.22% |
2012 | 8.30 | -6.55% |
2011 | 8.88 | 15.22% |
2010 | 7.71 | 10.37% |
2009 | 6.98 | -13.84% |
2008 | 8.10 | -29.92% |
2007 | 11.6 | -44.09% |
2006 | 20.7 | 137.23% |
2005 | 8.72 | -18.98% |
2004 | 10.8 | -9.46% |
2003 | 11.9 | 18.49% |
2002 | 10.0 | -59.52% |
2001 | 24.8 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 11.2 | -70.63% | ๐บ๐ธ USA |
Novartis NVS | 25.6 | -32.85% | ๐จ๐ญ Switzerland |
Pfizer PFE | 14.9 | -60.88% | ๐บ๐ธ USA |
Medtronic MDT | 32.0 | -16.30% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | 37.8 | -1.08% | ๐บ๐ธ USA |
Boston Scientific BSX | 83.7 | 119.18% | ๐บ๐ธ USA |
Hologic HOLX | 39.7 | 3.89% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 13.4 | -64.87% | ๐บ๐ธ USA |
AstraZeneca AZN | 34.4 | -9.93% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 12.3 | -67.84% | ๐ฌ๐ง UK |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.